Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk
Type 2 Diabetes Mellitus and Cardiovascular Disease Type 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1) T2DM in general increases the risk of CVD outcomes by a twofold and is independent of other risk factors. (1) The risk of coronary artery disease (CAD) in Indian T2DM patients is two to […]